Hospital Clinico Universitario de Salamanca;Servicio de Hematologia

Salamanca 37007

0 studies enrolling now · 4 studies all time

What they study most

B-cell Lymphoma, Chronic Lymphocytic Leukemia, Lymphoma, Lymphoma, Non-Hodgkin's

Studies at this site

• A Study of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Participants With Relapsed or Refractory Follicular or Diffuse Large B-Cell Lymphoma — Completed
• FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients — Completed
• A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma — Stopped early
• A Study of Revlimid in the Treatment of Non-Hodgkin's Lymphoma — Completed